Distinctive pathological and cytogenetic alterations distinguish familial BRCA1 and BRCA2 mutation-positive (+) from sporadic (non-familial) breast cancers. Using cDNA microarrays containing 6,500 ...

The accurate quantification of gene expression levels is crucial for transcriptome study. Microarray platforms are commonly used for simultaneously interrogating thousands of genes in the past decade, ...

Dublin, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The "Europe Microarray Analysis Market: Focus on Product, Type, Application, End User, and Country Level Analysis - Analysis and Forecast, 2023-2033" report ...

A Taiwan biotech company is diversifying its microarray offerings to deepen its imprint in Asia and to bolster the global acceptance of its genomic products and services. Phalanx Biotech Group is one ...

In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers. This study aimed to ...